BPC-157 Explained Simply
BPC-157 is an artificially produced peptide that has been studied mainly in animals; studies with a comparison group in humans are lacking.
1. What Is BPC-157?
BPC-157 is a peptide produced in the laboratory. A peptide is a short chain of building blocks, the amino acids. BPC-157 consists of 15 such building blocks. Its sequence corresponds to a section of a protein that occurs in human gastric juice. In this form, however, the peptide does not occur in the body itself. It is produced exclusively chemically and is not approved as a medicine.
2. Where Is It Found, and What Is It Made From?
BPC-157 does not occur in foods. It is produced exclusively artificially by peptide synthesis. It is mostly offered as a powder for dissolving for injections as well as in capsules. The research comes predominantly from animal experiments.
3. What Does BPC-157 Do? What Research Shows
| Area | State of research | Studies |
|---|---|---|
| Tendons, ligaments and muscles | still unclear | 3 |
| Joints and pain | still unclear | 5 |
| Stomach and gut | still unclear | 3 |
| Blood vessels and wound healing | still unclear | 4 |
| Other outcomes | still unclear | 8 |
Tendons, Ligaments and Muscles
For tendons, ligaments and muscles, there are no controlled studies (with a comparison group) in humans. The statements rely on reviews that evaluate almost only animal studies. In these animal studies, muscle, tendon, ligament and bone injuries healed better under BPC-157 1. One review article also describes better regeneration in tendons and junctions between muscle and tendon, predominantly from animal studies 3. Robust statements on the effect in humans cannot be derived from this.
Joints and Pain
For joints and pain, there are no controlled studies in humans, only small case series (description of several individual cases) and reviews. In a case series without a comparison group, knee pain improved after injection into the joint in most patients 2. One review article counts only three small preliminary studies in humans and considers larger studies with a comparison group necessary 3. Robust statements are not possible because comparison groups are lacking and the case series are small.
Stomach and Gut
For the stomach and intestines, there are no controlled studies in humans; only review articles exist. One review article describes healing effects in the gastrointestinal tract without naming results in humans in detail 4. Another review article describes BPC-157 in clinical studies in inflammatory bowel diseases as safe, but does not name any results on efficacy 5. The agent was tested as an injection, as a capsule and as a solution. How well it actually works in humans remains open because comparisons with an untreated group are lacking.
Blood Vessels and Wound Healing
For blood vessels and wound healing in humans, there are no controlled studies on BPC-157. One review article reports better new blood vessel formation and repair of the inner lining of blood vessels, but relies predominantly on animal and laboratory models 3. Another review article names effects on the healing of wounds and fistulas as well as on blood vessels without showing individual results in humans 4. BPC-157 was tested as an artificially produced peptide, partly as an injection, partly as a capsule or solution. Reliable evidence for a benefit in humans is lacking.
Other Outcomes
For this area, there are no controlled studies in humans. According to an organized summary of all studies, animal and laboratory experiments indicate that BPC-157 increases the docking sites for growth hormone and promotes the new formation of blood vessels 1. The same review describes fewer inflammatory messengers, also from animal and laboratory studies 1. Whether the agent works in humans remains open. The observations in humans ran without a comparison group, and the remaining studies come predominantly from the animal and laboratory area or are narrative.
4. How Was BPC-157 Taken in the Studies?
In the studies, BPC-157 was mostly injected as an artificially produced peptide: under the skin, into the muscle or into the joint. Individual works also looked at intake as a capsule or solution. In a case series, BPC-157 was injected into the joint together with thymosin beta-4 (TB4) 2.
5. Is BPC-157 Safe? Side Effects in the Studies
Two review articles report that BPC-157 showed no side effects in clinical studies 45. An organized summary of all studies, by contrast, found no safety data in humans and considers side effects possible due to unregulated production and impurities 1. Robust statements on benefits and risks in humans cannot be derived from the available data.
All details with tables and sources: full expert page on BPC-157
Sources
- 1Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE et al. · 2025
- 2Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainLee E, Padgett B · 2021
- 3McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM · 2025
- 4Sikiric P, Seiwerth S, Rucman R, Drmic D, Stupnisek M, Kokot A et al. · 2017
- 5Sikiric P, Seiwerth S, Brcic L, Sever M, Klicek R, Radic B et al. · 2010
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.